Natera, Inc. - Common Stock (NQ:NTRA)
All News about Natera, Inc. - Common Stock

Natera Reports Third Quarter 2023 Financial Results
November 08, 2023
From Natera, Inc.
Via Business Wire

Natera Announces Randomized, Phase III TREAT ctDNA Trial in Early-Stage Breast Cancer
November 08, 2023
From Natera, Inc.
Via Business Wire

Natera to Participate in November Investor Conferences
November 07, 2023
From Natera, Inc.
Via Business Wire


Analyst Ratings for Natera
October 16, 2023
Via Benzinga

The Latest Analyst Ratings for Natera
August 08, 2023
Via Benzinga




Natera to Report its Third Quarter 2023 Results on November 8
October 20, 2023
From Natera, Inc.
Via Business Wire






From Natera, Inc.
Via Business Wire

Natera Submits First PMA Module to the FDA for Signatera™
October 02, 2023
From Natera, Inc.
Via Business Wire

Natera Announces Senior Leadership Appointments
September 18, 2023
From Natera, Inc.
Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For September 28, 2023
September 28, 2023
Via Benzinga


Natera Announces Pricing of $250 Million Follow-On Offering
September 07, 2023
From Natera, Inc.
Via Business Wire


Natera to Participate in Upcoming Investor Conferences
September 01, 2023
From Natera, Inc.
Via Business Wire

From Natera, Inc.
Via Business Wire

12 Health Care Stocks Moving In Friday's Intraday Session
August 04, 2023
Via Benzinga




12 Health Care Stocks Moving In Friday's Pre-Market Session
August 04, 2023
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.